Following a similar decision in case the trade group Outsourcing Facilities Association brought against FDA over its decision ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

While they share similarities, there are differences, particularly between the drugs semaglutide and tirzepatide.

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Mississippi Attorney General Lynn Fitch is warning Mississippians of unapproved and compounded weight loss drugs.

Tirzapetide dose escalation schedules were slower in the real-world than clinical settings among individuals with obesity without T2D.